Why multi-use real estate is in demand for life sciences companies

India's Biocon, Enzene Biosciences, and Meteoric Biopharmacueticals, Japan's Daiichi Sankyo, and Singapore's Hummingbird Bioscience, have all recently sought to lease, acquire, and set up shop in a mixed-use space in the US. And for those companies who wish to enter or expand in the US market, New Jersey is a top choice due to its existing infrastructure, cultural connections, robust talent and location.

Some of the world’s most iconic resorts, Dubai’s Burj Al Arab for example, are purposefully designed so that guests never really have a reason to leave. There are multiple Michelin stars dotting the names of dozens of restaurants, couture shopping throughout, luxurious amenities around every corner, and boundless options for dazzling entertainment.

While “the world’s only 7-star hotel” isn’t exactly a realistic comparison to an office environment, it does offer inspiration and insight into the demand for mixed-use commercial space. At the end of the day, the average person will spend one-third of their life working. If people are going to allocate roughly 90,000 hours at work, shouldn’t we make the places they go to work a bit more enticing?

Some of the world’s top life sciences, biopharma, R&D, and clinical manufacturing companies think so. India’s Biocon, Enzene Biosciences, and Meteoric Biopharmacueticals, Japan’s Daiichi Sankyo, and Singapore’s Hummingbird Bioscience, have all recently sought to lease, acquire, and set up shop in a mixed-use space in the US. The reasons for the rise are as vast as the mixed-use amenities the facilities offer, but I think the shift can be summed up in a few key motivations.

Mixed-use commercial space helps companies: